Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2023 08:00 ET | Source: Neuronetics

Neuronetics Settles Litigation Against BrainsWay

MALVERN, Pa., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
January 09, 2023 08:30 ET | Source: Neuronetics

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results

MALVERN, Pa., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve...
December 29, 2022 16:29 ET | Source: Neuronetics

Neuronetics Announces Appointment of Joseph H. Capper to its Board of Directors

MALVERN, Pa., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever...
December 07, 2022 16:30 ET | Source: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
December 05, 2022 08:32 ET | Source: Neuronetics

Neuronetics Announced as a Winner by 2022 Merit Awards for HealthCare in the Patient Care Category

MALVERN, Pa., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
November 21, 2022 16:30 ET | Source: Neuronetics

Neuronetics to Present at the Piper Sandler 34th Annual Healthcare Conference

MALVERN, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
November 14, 2022 08:33 ET | Source: Neuronetics

Neuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations

MALVERN, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
November 09, 2022 20:04 ET | Source: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
November 08, 2022 07:30 ET | Source: Neuronetics

Neuronetics Reports Third Quarter 2022 Financial and Operating Results

MALVERN, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever...
October 31, 2022 08:31 ET | Source: Neuronetics

Neuronetics Announced as Winner by 2022 Merit Awards for Technology

MALVERN, Pa., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...